Molecular and clinical features of inherited neuropathies due to PMP22 duplication

Aarskog, 2000, Real-time quantitative polymerase chain reaction, Hum. Genet., 107, 494, 10.1007/s004390000399 Auer-Grumbach, 1998, Roussy–Lévy syndrome is a phenotypic variant of Charcot–Marie–Tooth syndrome IA associated with a duplication on chromosome 17p11.2, J. Neurol. Sci., 154, 72, 10.1016/S0022-510X(97)00218-9 Azzedine, 2012, Molecular genetics of Charcot–Marie–Tooth disease: from genes to genomes, Mol. Syndromol., 3, 204, 10.1159/000343487 Berciano, 2011, Charcot–Marie–Tooth disease: a review with emphasis on the pathophysiology of pes cavus, Rev. Esp. Cir. Ortop. Traumatol. (Engl. Ed.), 55, 140 Berciano, 2000, Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie–Tooth disease 1A duplication, Neuromuscul. Disord., 10, 419, 10.1016/S0960-8966(99)00114-5 Berciano, 2012, Guidelines for molecular diagnosis of Charcot–Marie–Tooth disease, Neurología (Engl. Ed.), 27, 169, 10.1016/j.nrleng.2012.04.006 Berciano, 2010, Clinical progression in Charcot–Marie–Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family, J. Neurol., 257, 1633, 10.1007/s00415-010-5580-x Blair, 1996, Prevalence and origin of de novo duplications in Charcot–Marie–Tooth disease type 1A: first report of a de novo duplication with a maternal origin, Am. J. Hum. Genet., 58, 472 Boerkoel, 1999, Molecular mechanism for CMT1A duplication and HNPP deletion, Ann. N. Y. Acad. Sci., 883, 22, 10.1111/j.1749-6632.1999.tb08563.x Braathen, 2011, Genetic epidemiology of Charcot–Marie–Tooth in the general population, Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc., 18, 39 Braathen, 2012, Genetic epidemiology of Charcot–Marie–Tooth disease, Acta Neurol. Scand. Suppl., 126, iv-22 Brice, 1992, Families of French ancestry with Charcot–Marie–Tooth disease type La, J. Med. Genet., 29, 807, 10.1136/jmg.29.11.807 Chance, 1993, DNA deletion associated with hereditary neuropathy with liability to pressure palsy, Cell, 72, 143, 10.1016/0092-8674(93)90058-X Colomban, 2014, Clinical spectrum and gender differences in a large cohort of Charcot–Marie–Tooth type 1A patients, J. Neurol. Sci., 336, 155, 10.1016/j.jns.2013.10.029 Corrado, 2006, Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot–Marie–Tooth disease type 1A, Cardiology, 105, 142, 10.1159/000091152 Chung, 2008, Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A, Neuromuscul. Disord., 18, 610, 10.1016/j.nmd.2008.05.012 D'Urso, 1997, Ins and outs of peripheral myelin protein-22: mapping transmembrane topology and intracellular sorting, J. Neurosci. Res., 49, 551, 10.1002/(SICI)1097-4547(19970901)49:5<551::AID-JNR5>3.0.CO;2-A D'Urso, 1999, Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin, J. Neurosci. Off. J. Soc. Neurosci., 19, 3396, 10.1523/JNEUROSCI.19-09-03396.1999 Fledrich, 2012, A rat model of Charcot–Marie–Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients, Brain, 135, 72, 10.1093/brain/awr322 Fortun, 2003, Emerging role for autophagy in the removal of aggresomes in Schwann cells, J. Neurosci., 23, 10672, 10.1523/JNEUROSCI.23-33-10672.2003 Fortun, 2006, Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression, Neurobiol. Dis., 22, 153, 10.1016/j.nbd.2005.10.010 García, 1998, Charcot–Marie–Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study, Neurology, 50, 1061, 10.1212/WNL.50.4.1061 Garcia, 1995, Clinical variability in two pairs of identical twins with the Charcot–Marie–Tooth disease type 1A duplication, Neurology, 45, 2090, 10.1212/WNL.45.11.2090 Gallardo, 2006, Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles, Brain, 129, 426, 10.1093/brain/awh693 Gentil, 2012, Molecular basis of axonal dysfunction and traffic impairments in CMT, Brain Res. Bull., 88, 444, 10.1016/j.brainresbull.2012.05.003 Gething, 1999, Role and regulation of the ER chaperone BiP, Semin. Cell Dev. Biol., 10, 465, 10.1006/scdb.1999.0318 Giambonini-Brugnoli, 2005, Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation, Neurobiol. Dis., 18, 656, 10.1016/j.nbd.2004.10.023 Hanemann, 1997, Schwann cell differentiation in Charcot–Marie–Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs, Acta Neuropathol., 94, 310, 10.1007/s004010050712 Hanemann, 1998, Pathogenesis of Charcot–Marie–Tooth 1A (CMT1A) neuropathy, Trends Neurosci., 21, 282, 10.1016/S0166-2236(97)01222-8 Hattori, 2003, Demyelinating and axonal features of Charcot–Marie–Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients, Brain, 126, 134, 10.1093/brain/awg012 Inoue, 2001, The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes, Genome Res., 11, 1018, 10.1101/gr.180401 Kaku, 1993, Nerve conduction studies in Charcot–Marie–Tooth polyneuropathy associated with a segmental duplication of chromosome 17, Neurology, 43, 1806, 10.1212/WNL.43.9.1806 Katona, 2009, PMP22 expression in dermal nerve myelin from patients with CMT1A, Brain J. Neurol., 132, 1734, 10.1093/brain/awp113 Kaya, 2007, Ascorbic acid inhibits PMP22 expression by reducing cAMP levels, Neuromuscul. Disord., 17, 248, 10.1016/j.nmd.2006.12.008 Khajavi, 2007, Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy, Am. J. Hum. Genet., 81, 438, 10.1086/519926 Kim, 2012, Comparison between clinical disabilities and electrophysiological values in Charcot–Marie–Tooth 1A patients with PMP22 duplication, J. Clin. Neurol. (Seoul, Korea), 8, 139, 10.3988/jcn.2012.8.2.139 Kleopa, 2011, The role of gap junctions in Charcot–Marie–Tooth disease, J. Neurosci. Off. J. Soc. Neurosci., 31, 17753, 10.1523/JNEUROSCI.4824-11.2011 Kosuka, 1997, Molecular and pathological studies in Charcot–Marie–Tooth disease 1A, Brain Dev., 19, 464, 10.1016/S0387-7604(97)00062-4 Kovach, 1999, A unique point mutation in the PMP22 gene is associated with Charcot–Marie–Tooth disease and deafness, Am. J. Hum. Genet., 64, 1580, 10.1086/302420 Krajewski, 2000, Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A, Brain J. Neurol., 123, 1516, 10.1093/brain/123.7.1516 Li, 2013, The PMP22 gene and its related diseases, Mol. Neurobiol., 47, 673, 10.1007/s12035-012-8370-x Lupski, 1991, DNA duplication associated with Charcot–Marie–Tooth type 1a, Cell, 66, 219, 10.1016/0092-8674(91)90613-4 Mobley, 2007, Purification and initiation of structural characterization of human peripheral myelin protein 22, an integral membrane protein linked to peripheral neuropathies, Biochemistry, 46, 11185, 10.1021/bi700855j Muller, 1997, MINIREVIEW advances in Charcot–Marie–Tooth-disease research : cellular function of CMT-related proteins, transgenic animal models, and pathomechanisms, Neurobiol. Dis., 220, 215, 10.1006/nbdi.1997.0148 Nicholson, 1991, Penetrance of the hereditary motor and sensory neuropathy Ia mutation: assessment by nerve conduction studies, Neurology, 41, 547, 10.1212/WNL.41.4.547 Nicolaou, 2010, Charcot–Marie–Tooth disease in Cyprus: epidemiological, clinical and genetic characteristics, Neuroepidemiology, 35, 171, 10.1159/000314351 Nobbio, 2009, P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy, J. Biol. Chem., 284, 23146, 10.1074/jbc.M109.027128 Nobbio, 2004, Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot–Marie–Tooth type 1A disease, Neurobiol. Dis., 16, 263, 10.1016/j.nbd.2004.02.007 Nobbio, 2014, The didanosine homodinucleotide P18 improves invitro myelination in experimental Charcot–Marie–Tooth disease type 1A, J. Cell Biochem., 115, 161, 10.1002/jcb.24644 Nodera, 2004, Nerve excitability properties in Charcot–Marie–Tooth disease type 1A, Brain J. Neurol., 127, 203, 10.1093/brain/awh020 Notterpek, 2001, Peripheral myelin protein 22 is a constituent of intercellular Junctions in epithelia, Proc. Natl. Acad. Sci. U. S. A., 98, 14404, 10.1073/pnas.251548398 Notterpek, 1999, PMP22 accumulation in aggresomes: implications for CMT1A pathology, Neurobiol. Dis., 6, 450, 10.1006/nbdi.1999.0274 Noto, 2015, Nerve ultrasound depicts peripheral nerve enlargement in patients with genetically distinct Charcot–Marie–Tooth disease, J. Neurol. Neurosurg. Psychiatry, 86, 378, 10.1136/jnnp-2014-308211 Padua, 2008, Natural history of CMT1A including QoL: a 2-year prospective study, Neuromuscul. Disord., 18, 199, 10.1016/j.nmd.2007.11.008 Pareyson, 2009, Diagnosis, natural history, and management of Charcot–Marie–Tooth disease, Lancet Neurol., 8, 654, 10.1016/S1474-4422(09)70110-3 Pazzaglia, 2013, Ultrasound assessment of sural nerve in Charcot–Marie–Tooth 1A neuropathy, Clin. Neurophysiol., 124, 1695, 10.1016/j.clinph.2013.02.020 Pleasure, 2005, Neurotrophin-3 therapy for Charcot–Marie–Tooth disease type 1a, Neurology, 65, 662, 10.1212/01.wnl.0000179404.82539.d7 Qayyum, 1990, Localization of a locus for Charcot–Marie–Tooth type La (CMTIA) to chromosome neuropathy, Genomics, 7, 408, 10.1016/0888-7543(90)90175-T Rance, 2012, Auditory function in children with Charcot–Marie–Tooth disease, Brain J. Neurol., 135, 1412, 10.1093/brain/aws085 Reilly, 2006, 136th ENMC International Workshop: Charcot–Marie–Tooth disease type 1A (CMT1A) 8–10 April 2005, Naarden, The Netherlands, Neuromuscul. Disord., 16, 396, 10.1016/j.nmd.2006.03.008 Reiter, 1999, Localization of mariner DNA transposons in the human genome by PRINS, Genome Res., 9, 839, 10.1101/gr.9.9.839 Reiter, 1996, A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element, Nat. Genet., 12, 288, 10.1038/ng0396-288 Ribiere, 2012, Pain assessment in Charcot–Marie–Tooth (CMT) disease, Ann. Phys. Rehab. Med., 55, 160, 10.1016/j.rehab.2012.02.005 Rossor, 2013, Clinical Implications of Genetic Advances in Charcot–Marie–Tooth Disease, 9 (10), 562 Saher, 2009, Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction, J. Neurosci., 29, 6094, 10.1523/JNEUROSCI.0686-09.2009 Sakakura, 2011, Structural basis for the Trembler-J phenotype of Charcot–Marie–Tooth disease, Structure (Lond. Engl. 1993), 19, 1160, 10.1016/j.str.2011.05.009 Sancho, 2001, Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot–Marie–Tooth disease type 1A, Brain, 124, 2177, 10.1093/brain/124.11.2177 Saporta, 2011, Charcot–Marie–Tooth disease subtypes and genetic testing strategies, Ann. Neurol., 69, 22, 10.1002/ana.22166 Sereda, 2003, Therapeutic administration of progesterone antagonist in a model of Charcot–Marie–Tooth disease (CMT-1A), Nat. Med., 9, 1533, 10.1038/nm957 Sinclair, 2011, MRI shows increased sciatic nerve cross sectional area in inherited and inflammatory neuropathies, J. Neurol. Neurosurg. Psychiatry, 82, 1283, 10.1136/jnnp.2010.211334 Suter, 1992, Trembler mouse carries a point mutation in a myelin gene, Nature, 356, 241, 10.1038/356241a0 Swan, 2007, Women and men are equally disabled by Charcot–Marie–Tooth disease type 1A, Neurology, 68, 873, 10.1212/01.wnl.0000256818.43819.da Timmerman, 2014, Genetics of Charcot–Marie–Tooth (CMT) disease within the frame of human genome project success, Genes, 5, 13, 10.3390/genes5010013 Taioli, 2011, Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene, Brain J. Neurol., 134, 608, 10.1093/brain/awq374 Taylor, 1995, Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family, J. Biol. Chem., 270, 28824, 10.1074/jbc.270.48.28824 Van Dijk, 2010, Age-related changes in motor unit number estimates in adult patients with Charcot–Marie–Tooth type 1A, Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc., 17, 1098 Verhagen, 2005, Sensorineural hearing impairment in patients with Pmp22 duplication, deletion, and frameshift mutations, Otol. Neurotol. Off. Publ. Am. Otol. Soc. Am. Neurotol. Soc. Eur. Acad. Otol. Neurotol., 26, 405, 10.1097/01.mao.0000169769.93173.df Verhamme, 2009, The natural history of Charcot–Marie–Tooth type 1A in adults: a 5-year follow-up study, Brain, 132, 3252, 10.1093/brain/awp251 Visser, 2014, Expert pearls for treating Charcot–Marie–Tooth disease, Podiatry Today, 27, 1 Wilmshurst, 2011, Hereditary peripheral neuropathies of childhood: an overview for clinicians, Neuromuscul. Disord., 21, 763, 10.1016/j.nmd.2011.05.013 Young, 2001, Disease mechanisms and potential therapeutic strategies in Charcot–Marie–Tooth disease, Brain Res. Brain Res. Rev., 36, 213, 10.1016/S0165-0173(01)00097-2 Zaidman, 2009, Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study, Muscle Nerve, 40, 960, 10.1002/mus.21431 Zhang, 2010, Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability, Am. J. Hum. Genet., 86, 892, 10.1016/j.ajhg.2010.05.001